Compositions and methods for improved in vitro assembly of polynucleotides
View Patent ↗Ordered assembly of large numbers of fragments into a single large DNA have been improved in both frequency and fidelity of the assembled product. This has been achieved by novel compositions and methods that are utilized in a computer system that integrates comprehensive ligation data from multiple sources to provide optimized synthetic overhangs or overhangs from restriction endonuclease cleavage on DNA fragments for assembly by ligation. Intragenic cut sites are avoided by the use of a novel restriction endonuclease which recognizes 7 nucleotides (bases) and cuts DNA to create 4-base overhangs with the help of a synthetic activator oligonucleotide. Variations in ligation preferences by different ligases provide extra precision in assembly reactions. The use of the improved methods are exemplified by the successful assembly from 52 fragments of a viral genome and also a 52 fragment ordered assembly of a bacteria operon.
1. A synthetic self-complementary oligonucleotide that comprises a double-stranded region and a single strand loop, wherein the double-stranded region contains a recognition sequence for PaqCI, has unligatable 3′ and 5′ ends and cannot be cleaved by PaqCI.
2. A reaction mixture, comprising:
(a) a synthetic self-complementary oligonucleotide comprising a double-stranded region and a single strand loop, wherein the double-stranded region contains a PaqCI recognition sequence, has unligatable 3′ and 5′ ends, and cannot be cleaved by PaqCI; and
(b) PaqCI or a variant thereof having an amino acid sequence that has at least 90% amino acid sequence identity with SEQ ID NO:1.
3. The reaction mixture according to claim 2 , wherein the double-stranded region is 10-50 base pairs in length.
4. The reaction mixture according to claim 2 , wherein the oligonucleotide is less than 110 nucleotides in length.
5. The reaction mixture according to claim 2 , wherein the 3′ end of the oligonucleotide is not a 3′ hydroxyl.
6. The reaction mixture according to claim 2 , wherein the 5′ end of the oligonucleotide is not a 5′ phosphate.
7. The oligonucleotide of claim 1 , wherein the recognition sequence is (5′-CACCTGC-3′/3′-GCAGGTG-5′).
8. The reaction mixture according to claim 2 , wherein the ratio of PaqCI to the synthetic self-complementary oligonucleotide is in the range of 1 unit PaqCI: 0.75 pmole-9 pmole oligonucleotide.
9. The reaction mixture of claim 2 , further comprising a double-stranded DNA substrate, wherein the substrate contains a recognition sequence for PaqCI and can be cleaved by PaqCI to produce a 4-base overhang.
10. The reaction mixture according to claim 9 , wherein the recognition sequence in the DNA substrate is (5′-CACCTGC-3′/3′-GCAGGTG-5′).
11. The reaction mixture of claim 2 , further comprising a DNA ligase.
12. The reaction mixture of claim 11 , wherein the DNA ligase is selected from the group consisting of T4 DNA ligase, T3 DNA ligase, T7 DNA ligase, PBCV-1 DNA ligase and human ligase 3 (hLig3).
13. The reaction mixture according to claim 2 , further comprising a plurality of plasmid or PCR products that contain fragments that are each flanked by recognition sites for PaqCI and wherein cleavage of the plasmid or PCR products by PaqCI or variant thereof produces fragments with different 4-base overhangs.
14. The reaction mixture of claim 11 , wherein the ratio of the PaqCI to ligase is 2.5-20 PaqCI Units to 200-800 ligase Units.
15. The reaction mixture according to claim 2 , wherein the reaction mixture further comprises one or more of: a DNA repair enzyme, a deadenylase, and/or a crowding agent.